These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2865808)

  • 1. [Modification of the growth of the gastric mucosa by drugs].
    Halter F
    Schweiz Med Wochenschr Suppl; 1985; 19():15-20. PubMed ID: 2865808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.
    Ono M; Sato H; Kazumori H; Yuki M; Rumi MA; Ortega-Cava CF; Ishihara Y; Ishihara S; Adachi K; Kinoshita Y
    J Lab Clin Med; 2003 Dec; 142(6):364-71. PubMed ID: 14713888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
    Larson GM; Sullivan HW; Rayford PL
    Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
    Kauffman GL
    J Clin Gastroenterol; 1981; 3(Suppl 2):95-101. PubMed ID: 6119340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of acid pump antagonists (reversible PPIs).
    Wurst W; Hartmann M
    Yale J Biol Med; 1996; 69(3):233-43. PubMed ID: 9165692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of gastric acid inhibition.
    Shamburek RD; Schubert ML
    Baillieres Clin Gastroenterol; 1993 Mar; 7(1):23-54. PubMed ID: 8097411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of gastric acid secretion: advantages and risks in short and long-term treatment.
    Mazzacca G; Sabbatini F
    Ital J Gastroenterol; 1990; 22 Suppl 1():11-2. PubMed ID: 1983419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
    Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Pajdo R; Drozdowicz D; Ptak A; Pawlik M; Stachura J; Pawlik WW; Hahn EG
    J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is hypergastrinaemia dangerous to man?
    Creutzfeldt W; Lamberts R
    Scand J Gastroenterol Suppl; 1991; 180():179-91. PubMed ID: 1675024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
    Nishi T; Makuuchi H; Weinstein WM
    Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of rat gastric mucosal response to potent acid inhibition.
    Nørsett KG; Laegreid A; Langaas M; Wörlund S; Fossmark R; Waldum HL; Sandvik AK
    Physiol Genomics; 2005 Jun; 22(1):24-32. PubMed ID: 15827235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
    Hirschowitz BI; Worthington J; Mohnen J; Haber M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine metabolism of gastric carcinoids in Mastomys natalensis.
    Kölby L; Wängberg B; Ahlman H; Modlin IM; Nilsson O
    Yale J Biol Med; 1998; 71(3-4):207-15. PubMed ID: 10461353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and toxicology of omeprazole--with special reference to the effects on the gastric mucosa.
    Carlsson E; Larsson H; Mattsson H; Ryberg B; Sundell G
    Scand J Gastroenterol Suppl; 1986; 118():31-8. PubMed ID: 3460170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric mucosal function following withdrawal of omeprazole in rats.
    Noto T; Nagasaki M; Yomota E; Endo T
    Arzneimittelforschung; 1998 Jan; 48(1):70-3. PubMed ID: 9522036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.